nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—BCHE—Cisplatin—germ cell cancer	0.149	0.305	CbGbCtD
Mefloquine—ABCB1—Dactinomycin—germ cell cancer	0.066	0.135	CbGbCtD
Mefloquine—CYP3A4—Ifosfamide—germ cell cancer	0.0467	0.0955	CbGbCtD
Mefloquine—ABCB1—Vinblastine—germ cell cancer	0.0414	0.0845	CbGbCtD
Mefloquine—CYP2D6—Vinblastine—germ cell cancer	0.039	0.0796	CbGbCtD
Mefloquine—ABCB1—Cisplatin—germ cell cancer	0.0379	0.0775	CbGbCtD
Mefloquine—ABCB1—Etoposide—germ cell cancer	0.0373	0.0761	CbGbCtD
Mefloquine—HBA2—dermis—germ cell cancer	0.0285	0.104	CbGeAlD
Mefloquine—CYP3A4—Vinblastine—germ cell cancer	0.0248	0.0506	CbGbCtD
Mefloquine—ABCB1—Methotrexate—germ cell cancer	0.0246	0.0503	CbGbCtD
Mefloquine—CYP3A4—Etoposide—germ cell cancer	0.0223	0.0456	CbGbCtD
Mefloquine—HBA1—urine—germ cell cancer	0.0161	0.0587	CbGeAlD
Mefloquine—HBA1—appendage—germ cell cancer	0.0157	0.0571	CbGeAlD
Mefloquine—HBA2—appendage—germ cell cancer	0.0144	0.0525	CbGeAlD
Mefloquine—CYP19A1—seminiferous tubule of testis—germ cell cancer	0.0117	0.0426	CbGeAlD
Mefloquine—HBA2—endothelium—germ cell cancer	0.0087	0.0317	CbGeAlD
Mefloquine—HBA2—blood vessel—germ cell cancer	0.00802	0.0292	CbGeAlD
Mefloquine—HBA2—neck—germ cell cancer	0.00574	0.0209	CbGeAlD
Mefloquine—ADORA2A—ganglion—germ cell cancer	0.00525	0.0191	CbGeAlD
Mefloquine—HBA2—embryo—germ cell cancer	0.00478	0.0174	CbGeAlD
Mefloquine—HBA1—brainstem—germ cell cancer	0.00477	0.0174	CbGeAlD
Mefloquine—HBA1—eye—germ cell cancer	0.00465	0.0169	CbGeAlD
Mefloquine—ADORA1—ganglion—germ cell cancer	0.00453	0.0165	CbGeAlD
Mefloquine—HBA2—eye—germ cell cancer	0.00427	0.0155	CbGeAlD
Mefloquine—HBA1—telencephalon—germ cell cancer	0.00424	0.0154	CbGeAlD
Mefloquine—HBA2—retina—germ cell cancer	0.00423	0.0154	CbGeAlD
Mefloquine—HBA1—skin of body—germ cell cancer	0.00404	0.0147	CbGeAlD
Mefloquine—HBA2—skin of body—germ cell cancer	0.00371	0.0135	CbGeAlD
Mefloquine—HBA1—adrenal gland—germ cell cancer	0.00308	0.0112	CbGeAlD
Mefloquine—HBA1—bone marrow—germ cell cancer	0.00298	0.0109	CbGeAlD
Mefloquine—HBA1—spinal cord—germ cell cancer	0.00297	0.0108	CbGeAlD
Mefloquine—HBA1—female gonad—germ cell cancer	0.00287	0.0105	CbGeAlD
Mefloquine—HBA2—adrenal gland—germ cell cancer	0.00283	0.0103	CbGeAlD
Mefloquine—HBA2—bone marrow—germ cell cancer	0.00274	0.00997	CbGeAlD
Mefloquine—HBA2—spinal cord—germ cell cancer	0.00273	0.00993	CbGeAlD
Mefloquine—HBA1—endocrine gland—germ cell cancer	0.00267	0.00973	CbGeAlD
Mefloquine—HBA1—head—germ cell cancer	0.00264	0.00961	CbGeAlD
Mefloquine—HBA2—female gonad—germ cell cancer	0.00264	0.00961	CbGeAlD
Mefloquine—HBA1—testis—germ cell cancer	0.00255	0.00928	CbGeAlD
Mefloquine—HBA2—endocrine gland—germ cell cancer	0.00245	0.00894	CbGeAlD
Mefloquine—HBA2—head—germ cell cancer	0.00242	0.00882	CbGeAlD
Mefloquine—HBA1—cerebellum—germ cell cancer	0.00235	0.00857	CbGeAlD
Mefloquine—HBA2—testis—germ cell cancer	0.00234	0.00852	CbGeAlD
Mefloquine—ADORA1—trigeminal ganglion—germ cell cancer	0.00223	0.00811	CbGeAlD
Mefloquine—ACHE—trigeminal ganglion—germ cell cancer	0.00221	0.00806	CbGeAlD
Mefloquine—CYP3A4—urine—germ cell cancer	0.00219	0.00797	CbGeAlD
Mefloquine—HBA2—cerebellum—germ cell cancer	0.00216	0.00787	CbGeAlD
Mefloquine—CYP2D6—urine—germ cell cancer	0.00215	0.00784	CbGeAlD
Mefloquine—ADORA2A—telencephalon—germ cell cancer	0.00203	0.00738	CbGeAlD
Mefloquine—HBA1—brain—germ cell cancer	0.00191	0.00696	CbGeAlD
Mefloquine—HBA1—lymph node—germ cell cancer	0.00185	0.00673	CbGeAlD
Mefloquine—HBA2—brain—germ cell cancer	0.00176	0.00639	CbGeAlD
Mefloquine—ADORA1—telencephalon—germ cell cancer	0.00175	0.00637	CbGeAlD
Mefloquine—ACHE—telencephalon—germ cell cancer	0.00174	0.00633	CbGeAlD
Mefloquine—HBA2—lymph node—germ cell cancer	0.0017	0.00618	CbGeAlD
Mefloquine—ADORA2A—gonad—germ cell cancer	0.00169	0.00616	CbGeAlD
Mefloquine—ADORA2A—adrenal gland—germ cell cancer	0.00147	0.00536	CbGeAlD
Mefloquine—ADORA2A—spinal cord—germ cell cancer	0.00142	0.00517	CbGeAlD
Mefloquine—ADORA1—medulla oblongata—germ cell cancer	0.00137	0.005	CbGeAlD
Mefloquine—ACHE—medulla oblongata—germ cell cancer	0.00137	0.00497	CbGeAlD
Mefloquine—ADORA2A—endocrine gland—germ cell cancer	0.00128	0.00465	CbGeAlD
Mefloquine—ACHE—adrenal gland—germ cell cancer	0.00126	0.0046	CbGeAlD
Mefloquine—ADORA2A—head—germ cell cancer	0.00126	0.00459	CbGeAlD
Mefloquine—ADORA1—midbrain—germ cell cancer	0.00126	0.00457	CbGeAlD
Mefloquine—ACHE—midbrain—germ cell cancer	0.00125	0.00455	CbGeAlD
Mefloquine—ADORA1—spinal cord—germ cell cancer	0.00123	0.00446	CbGeAlD
Mefloquine—ADORA2A—testis—germ cell cancer	0.00122	0.00444	CbGeAlD
Mefloquine—ACHE—spinal cord—germ cell cancer	0.00122	0.00443	CbGeAlD
Mefloquine—ADORA2A—cerebellum—germ cell cancer	0.00113	0.0041	CbGeAlD
Mefloquine—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00112	0.087	CbGpPWpGaD
Mefloquine—ADORA1—endocrine gland—germ cell cancer	0.0011	0.00402	CbGeAlD
Mefloquine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—KLF4—germ cell cancer	0.00109	0.0846	CbGpPWpGaD
Mefloquine—ADORA1—head—germ cell cancer	0.00109	0.00397	CbGeAlD
Mefloquine—BCHE—trigeminal ganglion—germ cell cancer	0.00109	0.00396	CbGeAlD
Mefloquine—ADORA1—testis—germ cell cancer	0.00105	0.00383	CbGeAlD
Mefloquine—ACHE—testis—germ cell cancer	0.00105	0.00381	CbGeAlD
Mefloquine—ADORA2A—HIF-2-alpha transcription factor network—POU5F1—germ cell cancer	0.000995	0.0773	CbGpPWpGaD
Mefloquine—CYP19A1—gonad—germ cell cancer	0.00099	0.0036	CbGeAlD
Mefloquine—CYP19A1—uterus—germ cell cancer	0.000983	0.00358	CbGeAlD
Mefloquine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—KLF4—germ cell cancer	0.000972	0.0755	CbGpPWpGaD
Mefloquine—ADORA1—cerebellum—germ cell cancer	0.000971	0.00354	CbGeAlD
Mefloquine—ACHE—cerebellum—germ cell cancer	0.000965	0.00352	CbGeAlD
Mefloquine—BCHE—brainstem—germ cell cancer	0.000962	0.00351	CbGeAlD
Mefloquine—ADORA2A—brain—germ cell cancer	0.000914	0.00333	CbGeAlD
Mefloquine—CYP19A1—adrenal gland—germ cell cancer	0.000863	0.00314	CbGeAlD
Mefloquine—BCHE—telencephalon—germ cell cancer	0.000854	0.00311	CbGeAlD
Mefloquine—ABCB1—blood vessel—germ cell cancer	0.000839	0.00306	CbGeAlD
Mefloquine—BCHE—skin of body—germ cell cancer	0.000815	0.00297	CbGeAlD
Mefloquine—CYP19A1—female gonad—germ cell cancer	0.000804	0.00293	CbGeAlD
Mefloquine—ADORA1—brain—germ cell cancer	0.000789	0.00287	CbGeAlD
Mefloquine—ACHE—brain—germ cell cancer	0.000784	0.00286	CbGeAlD
Mefloquine—ADORA1—lymph node—germ cell cancer	0.000762	0.00278	CbGeAlD
Mefloquine—ACHE—lymph node—germ cell cancer	0.000758	0.00276	CbGeAlD
Mefloquine—CYP19A1—endocrine gland—germ cell cancer	0.000748	0.00272	CbGeAlD
Mefloquine—CYP19A1—head—germ cell cancer	0.000738	0.00269	CbGeAlD
Mefloquine—Discomfort—Bleomycin—germ cell cancer	0.000728	0.00326	CcSEcCtD
Mefloquine—Malaise—Dactinomycin—germ cell cancer	0.000728	0.00326	CcSEcCtD
Mefloquine—Decreased appetite—Vinblastine—germ cell cancer	0.000727	0.00326	CcSEcCtD
Mefloquine—Leukopenia—Dactinomycin—germ cell cancer	0.000723	0.00324	CcSEcCtD
Mefloquine—Connective tissue disorder—Cisplatin—germ cell cancer	0.00072	0.00323	CcSEcCtD
Mefloquine—CYP19A1—testis—germ cell cancer	0.000713	0.0026	CbGeAlD
Mefloquine—Confusional state—Bleomycin—germ cell cancer	0.000713	0.00319	CcSEcCtD
Mefloquine—BCHE—uterus—germ cell cancer	0.000708	0.00258	CbGeAlD
Mefloquine—Hepatobiliary disease—Etoposide—germ cell cancer	0.000707	0.00317	CcSEcCtD
Mefloquine—Anaphylactic shock—Bleomycin—germ cell cancer	0.000707	0.00317	CcSEcCtD
Mefloquine—Oedema—Bleomycin—germ cell cancer	0.000707	0.00317	CcSEcCtD
Mefloquine—Visual impairment—Cisplatin—germ cell cancer	0.000706	0.00317	CcSEcCtD
Mefloquine—Agranulocytosis—Etoposide—germ cell cancer	0.000698	0.00313	CcSEcCtD
Mefloquine—Vision blurred—Ifosfamide—germ cell cancer	0.000697	0.00313	CcSEcCtD
Mefloquine—BCHE—pituitary gland—germ cell cancer	0.000695	0.00253	CbGeAlD
Mefloquine—Thrombocytopenia—Bleomycin—germ cell cancer	0.000692	0.0031	CcSEcCtD
Mefloquine—Feeling abnormal—Vinblastine—germ cell cancer	0.000689	0.00309	CcSEcCtD
Mefloquine—Myalgia—Dactinomycin—germ cell cancer	0.000688	0.00308	CcSEcCtD
Mefloquine—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000687	0.00308	CcSEcCtD
Mefloquine—Eye disorder—Cisplatin—germ cell cancer	0.000685	0.00307	CcSEcCtD
Mefloquine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000684	0.00307	CcSEcCtD
Mefloquine—Tinnitus—Cisplatin—germ cell cancer	0.000683	0.00306	CcSEcCtD
Mefloquine—Flushing—Cisplatin—germ cell cancer	0.00068	0.00305	CcSEcCtD
Mefloquine—Cardiac disorder—Cisplatin—germ cell cancer	0.00068	0.00305	CcSEcCtD
Mefloquine—Agitation—Ifosfamide—germ cell cancer	0.00068	0.00305	CcSEcCtD
Mefloquine—Discomfort—Dactinomycin—germ cell cancer	0.000679	0.00304	CcSEcCtD
Mefloquine—CYP19A1—Ovarian Infertility Genes—INHA—germ cell cancer	0.000677	0.0526	CbGpPWpGaD
Mefloquine—ADORA2A—Monoamine Transport—PVRL2—germ cell cancer	0.000673	0.0523	CbGpPWpGaD
Mefloquine—BCHE—medulla oblongata—germ cell cancer	0.000671	0.00244	CbGeAlD
Mefloquine—Malaise—Ifosfamide—germ cell cancer	0.000667	0.00299	CcSEcCtD
Mefloquine—Vertigo—Ifosfamide—germ cell cancer	0.000665	0.00298	CcSEcCtD
Mefloquine—Leukopenia—Ifosfamide—germ cell cancer	0.000662	0.00297	CcSEcCtD
Mefloquine—Abdominal pain—Vinblastine—germ cell cancer	0.000661	0.00296	CcSEcCtD
Mefloquine—Mediastinal disorder—Cisplatin—germ cell cancer	0.00066	0.00296	CcSEcCtD
Mefloquine—Hypotension—Bleomycin—germ cell cancer	0.00066	0.00296	CcSEcCtD
Mefloquine—Oedema—Dactinomycin—germ cell cancer	0.000659	0.00295	CcSEcCtD
Mefloquine—Palpitations—Ifosfamide—germ cell cancer	0.000654	0.00293	CcSEcCtD
Mefloquine—Alopecia—Cisplatin—germ cell cancer	0.000648	0.0029	CcSEcCtD
Mefloquine—Hepatic failure—Methotrexate—germ cell cancer	0.000647	0.0029	CcSEcCtD
Mefloquine—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000645	0.00289	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000644	0.00289	CcSEcCtD
Mefloquine—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000643	0.0499	CbGpPWpGaD
Mefloquine—Convulsion—Ifosfamide—germ cell cancer	0.000641	0.00287	CcSEcCtD
Mefloquine—Hypertension—Ifosfamide—germ cell cancer	0.000639	0.00286	CcSEcCtD
Mefloquine—Malnutrition—Cisplatin—germ cell cancer	0.000638	0.00286	CcSEcCtD
Mefloquine—Erythema—Cisplatin—germ cell cancer	0.000638	0.00286	CcSEcCtD
Mefloquine—CYP2D6—brainstem—germ cell cancer	0.000638	0.00232	CbGeAlD
Mefloquine—Erythema multiforme—Etoposide—germ cell cancer	0.000635	0.00285	CcSEcCtD
Mefloquine—Paraesthesia—Bleomycin—germ cell cancer	0.000635	0.00284	CcSEcCtD
Mefloquine—Dyspnoea—Bleomycin—germ cell cancer	0.00063	0.00282	CcSEcCtD
Mefloquine—Myalgia—Ifosfamide—germ cell cancer	0.00063	0.00282	CcSEcCtD
Mefloquine—Arthralgia—Ifosfamide—germ cell cancer	0.00063	0.00282	CcSEcCtD
Mefloquine—Chest pain—Ifosfamide—germ cell cancer	0.00063	0.00282	CcSEcCtD
Mefloquine—Eye disorder—Etoposide—germ cell cancer	0.000627	0.00281	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000626	0.0028	CcSEcCtD
Mefloquine—Cardiac disorder—Etoposide—germ cell cancer	0.000623	0.00279	CcSEcCtD
Mefloquine—Flushing—Etoposide—germ cell cancer	0.000623	0.00279	CcSEcCtD
Mefloquine—Discomfort—Ifosfamide—germ cell cancer	0.000622	0.00279	CcSEcCtD
Mefloquine—BCHE—adrenal gland—germ cell cancer	0.000621	0.00226	CbGeAlD
Mefloquine—Hypersensitivity—Vinblastine—germ cell cancer	0.000616	0.00276	CcSEcCtD
Mefloquine—Decreased appetite—Bleomycin—germ cell cancer	0.000614	0.00275	CcSEcCtD
Mefloquine—Visual disturbance—Methotrexate—germ cell cancer	0.000613	0.00275	CcSEcCtD
Mefloquine—Muscle spasms—Cisplatin—germ cell cancer	0.000613	0.00275	CcSEcCtD
Mefloquine—BCHE—midbrain—germ cell cancer	0.000613	0.00223	CbGeAlD
Mefloquine—Angiopathy—Etoposide—germ cell cancer	0.000609	0.00273	CcSEcCtD
Mefloquine—Confusional state—Ifosfamide—germ cell cancer	0.000609	0.00273	CcSEcCtD
Mefloquine—Mediastinal disorder—Etoposide—germ cell cancer	0.000605	0.00271	CcSEcCtD
Mefloquine—Oedema—Ifosfamide—germ cell cancer	0.000604	0.00271	CcSEcCtD
Mefloquine—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000604	0.00271	CcSEcCtD
Mefloquine—Chills—Etoposide—germ cell cancer	0.000602	0.0027	CcSEcCtD
Mefloquine—Vision blurred—Cisplatin—germ cell cancer	0.000601	0.0027	CcSEcCtD
Mefloquine—BCHE—bone marrow—germ cell cancer	0.000601	0.00219	CbGeAlD
Mefloquine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.0006	0.00269	CcSEcCtD
Mefloquine—Asthenia—Vinblastine—germ cell cancer	0.0006	0.00269	CcSEcCtD
Mefloquine—BCHE—spinal cord—germ cell cancer	0.000598	0.00218	CbGeAlD
Mefloquine—Tremor—Cisplatin—germ cell cancer	0.000598	0.00268	CcSEcCtD
Mefloquine—Alopecia—Etoposide—germ cell cancer	0.000593	0.00266	CcSEcCtD
Mefloquine—Nervous system disorder—Ifosfamide—germ cell cancer	0.000592	0.00265	CcSEcCtD
Mefloquine—Ill-defined disorder—Cisplatin—germ cell cancer	0.000592	0.00265	CcSEcCtD
Mefloquine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000591	0.00265	CcSEcCtD
Mefloquine—Skin disorder—Ifosfamide—germ cell cancer	0.000587	0.00263	CcSEcCtD
Mefloquine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000584	0.00262	CcSEcCtD
Mefloquine—Feeling abnormal—Bleomycin—germ cell cancer	0.000582	0.00261	CcSEcCtD
Mefloquine—Malaise—Cisplatin—germ cell cancer	0.000575	0.00258	CcSEcCtD
Mefloquine—Decreased appetite—Dactinomycin—germ cell cancer	0.000573	0.00257	CcSEcCtD
Mefloquine—Diarrhoea—Vinblastine—germ cell cancer	0.000572	0.00257	CcSEcCtD
Mefloquine—Leukopenia—Cisplatin—germ cell cancer	0.000571	0.00256	CcSEcCtD
Mefloquine—Fatigue—Dactinomycin—germ cell cancer	0.000568	0.00255	CcSEcCtD
Mefloquine—CYP2D6—telencephalon—germ cell cancer	0.000566	0.00206	CbGeAlD
Mefloquine—Hypotension—Ifosfamide—germ cell cancer	0.000564	0.00253	CcSEcCtD
Mefloquine—Muscle spasms—Etoposide—germ cell cancer	0.000562	0.00252	CcSEcCtD
Mefloquine—Urticaria—Bleomycin—germ cell cancer	0.000561	0.00252	CcSEcCtD
Mefloquine—Body temperature increased—Bleomycin—germ cell cancer	0.000559	0.0025	CcSEcCtD
Mefloquine—Irritability—Methotrexate—germ cell cancer	0.000555	0.00249	CcSEcCtD
Mefloquine—Dizziness—Vinblastine—germ cell cancer	0.000553	0.00248	CcSEcCtD
Mefloquine—Convulsion—Cisplatin—germ cell cancer	0.000553	0.00248	CcSEcCtD
Mefloquine—Mood swings—Methotrexate—germ cell cancer	0.000551	0.00247	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00055	0.00247	CcSEcCtD
Mefloquine—Ataxia—Methotrexate—germ cell cancer	0.000547	0.00245	CcSEcCtD
Mefloquine—Myalgia—Cisplatin—germ cell cancer	0.000543	0.00243	CcSEcCtD
Mefloquine—Feeling abnormal—Dactinomycin—germ cell cancer	0.000543	0.00243	CcSEcCtD
Mefloquine—Paraesthesia—Ifosfamide—germ cell cancer	0.000542	0.00243	CcSEcCtD
Mefloquine—Ill-defined disorder—Etoposide—germ cell cancer	0.000542	0.00243	CcSEcCtD
Mefloquine—Anxiety—Cisplatin—germ cell cancer	0.000541	0.00243	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000539	0.00242	CcSEcCtD
Mefloquine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000539	0.00242	CcSEcCtD
Mefloquine—BCHE—endocrine gland—germ cell cancer	0.000539	0.00196	CbGeAlD
Mefloquine—Dyspnoea—Ifosfamide—germ cell cancer	0.000538	0.00241	CcSEcCtD
Mefloquine—ACHE—Monoamine Transport—PVRL2—germ cell cancer	0.000537	0.0418	CbGpPWpGaD
Mefloquine—Somnolence—Ifosfamide—germ cell cancer	0.000537	0.00241	CcSEcCtD
Mefloquine—Discomfort—Cisplatin—germ cell cancer	0.000537	0.00241	CcSEcCtD
Mefloquine—CYP19A1—brain—germ cell cancer	0.000535	0.00195	CbGeAlD
Mefloquine—Vomiting—Vinblastine—germ cell cancer	0.000532	0.00238	CcSEcCtD
Mefloquine—BCHE—head—germ cell cancer	0.000532	0.00194	CbGeAlD
Mefloquine—Malaise—Etoposide—germ cell cancer	0.000527	0.00236	CcSEcCtD
Mefloquine—Vertigo—Etoposide—germ cell cancer	0.000525	0.00235	CcSEcCtD
Mefloquine—Decreased appetite—Ifosfamide—germ cell cancer	0.000525	0.00235	CcSEcCtD
Mefloquine—Headache—Vinblastine—germ cell cancer	0.000524	0.00235	CcSEcCtD
Mefloquine—Leukopenia—Etoposide—germ cell cancer	0.000523	0.00235	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000521	0.00234	CcSEcCtD
Mefloquine—Body temperature increased—Dactinomycin—germ cell cancer	0.000521	0.00234	CcSEcCtD
Mefloquine—Abdominal pain—Dactinomycin—germ cell cancer	0.000521	0.00234	CcSEcCtD
Mefloquine—Fatigue—Ifosfamide—germ cell cancer	0.000521	0.00233	CcSEcCtD
Mefloquine—Anaphylactic shock—Cisplatin—germ cell cancer	0.000521	0.00233	CcSEcCtD
Mefloquine—Oedema—Cisplatin—germ cell cancer	0.000521	0.00233	CcSEcCtD
Mefloquine—Hypersensitivity—Bleomycin—germ cell cancer	0.000521	0.00233	CcSEcCtD
Mefloquine—ABCB1—trigeminal ganglion—germ cell cancer	0.000518	0.00189	CbGeAlD
Mefloquine—CYP19A1—lymph node—germ cell cancer	0.000517	0.00188	CbGeAlD
Mefloquine—BCHE—testis—germ cell cancer	0.000514	0.00187	CbGeAlD
Mefloquine—CYP19A1—Metapathway biotransformation—NAT9—germ cell cancer	0.000514	0.0399	CbGpPWpGaD
Mefloquine—Loss of consciousness—Etoposide—germ cell cancer	0.000514	0.0023	CcSEcCtD
Mefloquine—Nervous system disorder—Cisplatin—germ cell cancer	0.000511	0.00229	CcSEcCtD
Mefloquine—Thrombocytopenia—Cisplatin—germ cell cancer	0.00051	0.00229	CcSEcCtD
Mefloquine—Tachycardia—Cisplatin—germ cell cancer	0.000508	0.00228	CcSEcCtD
Mefloquine—Asthenia—Bleomycin—germ cell cancer	0.000507	0.00227	CcSEcCtD
Mefloquine—Convulsion—Etoposide—germ cell cancer	0.000506	0.00227	CcSEcCtD
Mefloquine—Skin disorder—Cisplatin—germ cell cancer	0.000506	0.00227	CcSEcCtD
Mefloquine—Hypertension—Etoposide—germ cell cancer	0.000505	0.00226	CcSEcCtD
Mefloquine—Hyperhidrosis—Cisplatin—germ cell cancer	0.000503	0.00226	CcSEcCtD
Mefloquine—ABCB1—embryo—germ cell cancer	0.0005	0.00182	CbGeAlD
Mefloquine—Pruritus—Bleomycin—germ cell cancer	0.0005	0.00224	CcSEcCtD
Mefloquine—Feeling abnormal—Ifosfamide—germ cell cancer	0.000498	0.00223	CcSEcCtD
Mefloquine—Chest pain—Etoposide—germ cell cancer	0.000498	0.00223	CcSEcCtD
Mefloquine—Nausea—Vinblastine—germ cell cancer	0.000497	0.00223	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000494	0.00222	CcSEcCtD
Mefloquine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000494	0.00221	CcSEcCtD
Mefloquine—Discomfort—Etoposide—germ cell cancer	0.000492	0.0022	CcSEcCtD
Mefloquine—Hypotension—Cisplatin—germ cell cancer	0.000487	0.00218	CcSEcCtD
Mefloquine—Hypersensitivity—Dactinomycin—germ cell cancer	0.000486	0.00218	CcSEcCtD
Mefloquine—Confusional state—Etoposide—germ cell cancer	0.000481	0.00216	CcSEcCtD
Mefloquine—Urticaria—Ifosfamide—germ cell cancer	0.00048	0.00215	CcSEcCtD
Mefloquine—Abdominal pain—Ifosfamide—germ cell cancer	0.000477	0.00214	CcSEcCtD
Mefloquine—Body temperature increased—Ifosfamide—germ cell cancer	0.000477	0.00214	CcSEcCtD
Mefloquine—Anaphylactic shock—Etoposide—germ cell cancer	0.000477	0.00214	CcSEcCtD
Mefloquine—BCHE—cerebellum—germ cell cancer	0.000474	0.00173	CbGeAlD
Mefloquine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000474	0.00213	CcSEcCtD
Mefloquine—Asthenia—Dactinomycin—germ cell cancer	0.000473	0.00212	CcSEcCtD
Mefloquine—Paraesthesia—Cisplatin—germ cell cancer	0.000468	0.0021	CcSEcCtD
Mefloquine—Thrombocytopenia—Etoposide—germ cell cancer	0.000467	0.00209	CcSEcCtD
Mefloquine—Tachycardia—Etoposide—germ cell cancer	0.000466	0.00209	CcSEcCtD
Mefloquine—Dyspnoea—Cisplatin—germ cell cancer	0.000464	0.00208	CcSEcCtD
Mefloquine—Skin disorder—Etoposide—germ cell cancer	0.000463	0.00208	CcSEcCtD
Mefloquine—Hyperhidrosis—Etoposide—germ cell cancer	0.000461	0.00207	CcSEcCtD
Mefloquine—Decreased appetite—Cisplatin—germ cell cancer	0.000453	0.00203	CcSEcCtD
Mefloquine—Diarrhoea—Dactinomycin—germ cell cancer	0.000451	0.00202	CcSEcCtD
Mefloquine—Pneumonia—Methotrexate—germ cell cancer	0.000451	0.00202	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00045	0.00202	CcSEcCtD
Mefloquine—Vomiting—Bleomycin—germ cell cancer	0.000449	0.00201	CcSEcCtD
Mefloquine—Hypotension—Etoposide—germ cell cancer	0.000446	0.002	CcSEcCtD
Mefloquine—Rash—Bleomycin—germ cell cancer	0.000446	0.002	CcSEcCtD
Mefloquine—Dermatitis—Bleomycin—germ cell cancer	0.000445	0.002	CcSEcCtD
Mefloquine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000445	0.00199	CcSEcCtD
Mefloquine—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000444	0.00199	CcSEcCtD
Mefloquine—ABCB1—retina—germ cell cancer	0.000442	0.00161	CbGeAlD
Mefloquine—Renal failure—Methotrexate—germ cell cancer	0.00044	0.00197	CcSEcCtD
Mefloquine—Asthenia—Ifosfamide—germ cell cancer	0.000433	0.00194	CcSEcCtD
Mefloquine—Sweating—Methotrexate—germ cell cancer	0.000429	0.00193	CcSEcCtD
Mefloquine—Feeling abnormal—Cisplatin—germ cell cancer	0.000429	0.00192	CcSEcCtD
Mefloquine—Paraesthesia—Etoposide—germ cell cancer	0.000428	0.00192	CcSEcCtD
Mefloquine—Pruritus—Ifosfamide—germ cell cancer	0.000427	0.00192	CcSEcCtD
Mefloquine—Dyspnoea—Etoposide—germ cell cancer	0.000425	0.00191	CcSEcCtD
Mefloquine—Somnolence—Etoposide—germ cell cancer	0.000424	0.0019	CcSEcCtD
Mefloquine—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000424	0.0019	CcSEcCtD
Mefloquine—Nausea—Bleomycin—germ cell cancer	0.00042	0.00188	CcSEcCtD
Mefloquine—Vomiting—Dactinomycin—germ cell cancer	0.000419	0.00188	CcSEcCtD
Mefloquine—Agranulocytosis—Methotrexate—germ cell cancer	0.000418	0.00187	CcSEcCtD
Mefloquine—Rash—Dactinomycin—germ cell cancer	0.000416	0.00186	CcSEcCtD
Mefloquine—Decreased appetite—Etoposide—germ cell cancer	0.000415	0.00186	CcSEcCtD
Mefloquine—Diarrhoea—Ifosfamide—germ cell cancer	0.000413	0.00185	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000412	0.00185	CcSEcCtD
Mefloquine—Body temperature increased—Cisplatin—germ cell cancer	0.000412	0.00185	CcSEcCtD
Mefloquine—Fatigue—Etoposide—germ cell cancer	0.000411	0.00184	CcSEcCtD
Mefloquine—ABCB1—telencephalon—germ cell cancer	0.000407	0.00148	CbGeAlD
Mefloquine—Dizziness—Ifosfamide—germ cell cancer	0.000399	0.00179	CcSEcCtD
Mefloquine—Feeling abnormal—Etoposide—germ cell cancer	0.000393	0.00176	CcSEcCtD
Mefloquine—Nausea—Dactinomycin—germ cell cancer	0.000391	0.00175	CcSEcCtD
Mefloquine—Gastrointestinal pain—Etoposide—germ cell cancer	0.00039	0.00175	CcSEcCtD
Mefloquine—Visual impairment—Methotrexate—germ cell cancer	0.000388	0.00174	CcSEcCtD
Mefloquine—ABCB1—decidua—germ cell cancer	0.000386	0.00141	CbGeAlD
Mefloquine—BCHE—brain—germ cell cancer	0.000385	0.0014	CbGeAlD
Mefloquine—Vomiting—Ifosfamide—germ cell cancer	0.000384	0.00172	CcSEcCtD
Mefloquine—CYP2D6—female gonad—germ cell cancer	0.000384	0.0014	CbGeAlD
Mefloquine—Hypersensitivity—Cisplatin—germ cell cancer	0.000384	0.00172	CcSEcCtD
Mefloquine—Rash—Ifosfamide—germ cell cancer	0.000381	0.00171	CcSEcCtD
Mefloquine—Dermatitis—Ifosfamide—germ cell cancer	0.00038	0.00171	CcSEcCtD
Mefloquine—Erythema multiforme—Methotrexate—germ cell cancer	0.00038	0.0017	CcSEcCtD
Mefloquine—Urticaria—Etoposide—germ cell cancer	0.000379	0.0017	CcSEcCtD
Mefloquine—Body temperature increased—Etoposide—germ cell cancer	0.000377	0.00169	CcSEcCtD
Mefloquine—Abdominal pain—Etoposide—germ cell cancer	0.000377	0.00169	CcSEcCtD
Mefloquine—Eye disorder—Methotrexate—germ cell cancer	0.000376	0.00168	CcSEcCtD
Mefloquine—Tinnitus—Methotrexate—germ cell cancer	0.000375	0.00168	CcSEcCtD
Mefloquine—Asthenia—Cisplatin—germ cell cancer	0.000374	0.00167	CcSEcCtD
Mefloquine—Cardiac disorder—Methotrexate—germ cell cancer	0.000373	0.00167	CcSEcCtD
Mefloquine—BCHE—lymph node—germ cell cancer	0.000372	0.00136	CbGeAlD
Mefloquine—Angiopathy—Methotrexate—germ cell cancer	0.000365	0.00164	CcSEcCtD
Mefloquine—CYP3A4—endocrine gland—germ cell cancer	0.000363	0.00132	CbGeAlD
Mefloquine—Mediastinal disorder—Methotrexate—germ cell cancer	0.000362	0.00162	CcSEcCtD
Mefloquine—Chills—Methotrexate—germ cell cancer	0.000361	0.00162	CcSEcCtD
Mefloquine—Nausea—Ifosfamide—germ cell cancer	0.000359	0.00161	CcSEcCtD
Mefloquine—CYP2D6—endocrine gland—germ cell cancer	0.000357	0.0013	CbGeAlD
Mefloquine—Diarrhoea—Cisplatin—germ cell cancer	0.000356	0.0016	CcSEcCtD
Mefloquine—Alopecia—Methotrexate—germ cell cancer	0.000355	0.00159	CcSEcCtD
Mefloquine—CYP2D6—head—germ cell cancer	0.000352	0.00128	CbGeAlD
Mefloquine—Mental disorder—Methotrexate—germ cell cancer	0.000352	0.00158	CcSEcCtD
Mefloquine—Hypersensitivity—Etoposide—germ cell cancer	0.000351	0.00158	CcSEcCtD
Mefloquine—Malnutrition—Methotrexate—germ cell cancer	0.00035	0.00157	CcSEcCtD
Mefloquine—Erythema—Methotrexate—germ cell cancer	0.00035	0.00157	CcSEcCtD
Mefloquine—Asthenia—Etoposide—germ cell cancer	0.000342	0.00153	CcSEcCtD
Mefloquine—CYP2D6—testis—germ cell cancer	0.00034	0.00124	CbGeAlD
Mefloquine—ABCB1—gonad—germ cell cancer	0.00034	0.00124	CbGeAlD
Mefloquine—ABCB1—uterus—germ cell cancer	0.000337	0.00123	CbGeAlD
Mefloquine—Pruritus—Etoposide—germ cell cancer	0.000337	0.00151	CcSEcCtD
Mefloquine—ACHE—Peptide hormone metabolism—INHA—germ cell cancer	0.000337	0.0262	CbGpPWpGaD
Mefloquine—ABCB1—pituitary gland—germ cell cancer	0.000331	0.00121	CbGeAlD
Mefloquine—Vomiting—Cisplatin—germ cell cancer	0.000331	0.00148	CcSEcCtD
Mefloquine—Vision blurred—Methotrexate—germ cell cancer	0.00033	0.00148	CcSEcCtD
Mefloquine—Rash—Cisplatin—germ cell cancer	0.000328	0.00147	CcSEcCtD
Mefloquine—Dermatitis—Cisplatin—germ cell cancer	0.000328	0.00147	CcSEcCtD
Mefloquine—Diarrhoea—Etoposide—germ cell cancer	0.000326	0.00146	CcSEcCtD
Mefloquine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000325	0.00146	CcSEcCtD
Mefloquine—ABCB1—medulla oblongata—germ cell cancer	0.00032	0.00116	CbGeAlD
Mefloquine—Malaise—Methotrexate—germ cell cancer	0.000316	0.00142	CcSEcCtD
Mefloquine—Dizziness—Etoposide—germ cell cancer	0.000315	0.00141	CcSEcCtD
Mefloquine—Vertigo—Methotrexate—germ cell cancer	0.000315	0.00141	CcSEcCtD
Mefloquine—CYP2D6—cerebellum—germ cell cancer	0.000314	0.00114	CbGeAlD
Mefloquine—Leukopenia—Methotrexate—germ cell cancer	0.000313	0.0014	CcSEcCtD
Mefloquine—Nausea—Cisplatin—germ cell cancer	0.000309	0.00139	CcSEcCtD
Mefloquine—Convulsion—Methotrexate—germ cell cancer	0.000303	0.00136	CcSEcCtD
Mefloquine—Vomiting—Etoposide—germ cell cancer	0.000303	0.00136	CcSEcCtD
Mefloquine—BCHE—Peptide hormone metabolism—INHA—germ cell cancer	0.000301	0.0234	CbGpPWpGaD
Mefloquine—Rash—Etoposide—germ cell cancer	0.000301	0.00135	CcSEcCtD
Mefloquine—ACHE—Peptide hormone metabolism—KLF4—germ cell cancer	0.000301	0.0234	CbGpPWpGaD
Mefloquine—Dermatitis—Etoposide—germ cell cancer	0.0003	0.00135	CcSEcCtD
Mefloquine—Headache—Etoposide—germ cell cancer	0.000299	0.00134	CcSEcCtD
Mefloquine—Chest pain—Methotrexate—germ cell cancer	0.000298	0.00134	CcSEcCtD
Mefloquine—Arthralgia—Methotrexate—germ cell cancer	0.000298	0.00134	CcSEcCtD
Mefloquine—Myalgia—Methotrexate—germ cell cancer	0.000298	0.00134	CcSEcCtD
Mefloquine—ABCB1—adrenal gland—germ cell cancer	0.000296	0.00108	CbGeAlD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000296	0.00133	CcSEcCtD
Mefloquine—Discomfort—Methotrexate—germ cell cancer	0.000294	0.00132	CcSEcCtD
Mefloquine—ABCB1—midbrain—germ cell cancer	0.000292	0.00106	CbGeAlD
Mefloquine—Confusional state—Methotrexate—germ cell cancer	0.000288	0.00129	CcSEcCtD
Mefloquine—ABCB1—bone marrow—germ cell cancer	0.000286	0.00104	CbGeAlD
Mefloquine—Anaphylactic shock—Methotrexate—germ cell cancer	0.000286	0.00128	CcSEcCtD
Mefloquine—ABCB1—spinal cord—germ cell cancer	0.000285	0.00104	CbGeAlD
Mefloquine—Nausea—Etoposide—germ cell cancer	0.000283	0.00127	CcSEcCtD
Mefloquine—Nervous system disorder—Methotrexate—germ cell cancer	0.00028	0.00126	CcSEcCtD
Mefloquine—Thrombocytopenia—Methotrexate—germ cell cancer	0.00028	0.00125	CcSEcCtD
Mefloquine—Skin disorder—Methotrexate—germ cell cancer	0.000278	0.00124	CcSEcCtD
Mefloquine—Hyperhidrosis—Methotrexate—germ cell cancer	0.000276	0.00124	CcSEcCtD
Mefloquine—ABCB1—female gonad—germ cell cancer	0.000276	0.00101	CbGeAlD
Mefloquine—BCHE—Peptide hormone metabolism—KLF4—germ cell cancer	0.000268	0.0208	CbGpPWpGaD
Mefloquine—Hypotension—Methotrexate—germ cell cancer	0.000267	0.0012	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.00026	0.00117	CcSEcCtD
Mefloquine—Insomnia—Methotrexate—germ cell cancer	0.000258	0.00116	CcSEcCtD
Mefloquine—ABCB1—endocrine gland—germ cell cancer	0.000257	0.000935	CbGeAlD
Mefloquine—Paraesthesia—Methotrexate—germ cell cancer	0.000257	0.00115	CcSEcCtD
Mefloquine—CYP2D6—brain—germ cell cancer	0.000255	0.00093	CbGeAlD
Mefloquine—Dyspnoea—Methotrexate—germ cell cancer	0.000255	0.00114	CcSEcCtD
Mefloquine—Somnolence—Methotrexate—germ cell cancer	0.000254	0.00114	CcSEcCtD
Mefloquine—ABCB1—head—germ cell cancer	0.000253	0.000923	CbGeAlD
Mefloquine—Dyspepsia—Methotrexate—germ cell cancer	0.000252	0.00113	CcSEcCtD
Mefloquine—Decreased appetite—Methotrexate—germ cell cancer	0.000248	0.00111	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000247	0.00111	CcSEcCtD
Mefloquine—Fatigue—Methotrexate—germ cell cancer	0.000246	0.0011	CcSEcCtD
Mefloquine—ABCB1—testis—germ cell cancer	0.000245	0.000892	CbGeAlD
Mefloquine—HBA1—Folate Metabolism—TP53—germ cell cancer	0.00024	0.0186	CbGpPWpGaD
Mefloquine—Feeling abnormal—Methotrexate—germ cell cancer	0.000235	0.00106	CcSEcCtD
Mefloquine—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000234	0.00105	CcSEcCtD
Mefloquine—CYP2D6—Metapathway biotransformation—NAT9—germ cell cancer	0.000229	0.0178	CbGpPWpGaD
Mefloquine—Urticaria—Methotrexate—germ cell cancer	0.000227	0.00102	CcSEcCtD
Mefloquine—ABCB1—cerebellum—germ cell cancer	0.000226	0.000824	CbGeAlD
Mefloquine—Body temperature increased—Methotrexate—germ cell cancer	0.000226	0.00101	CcSEcCtD
Mefloquine—Abdominal pain—Methotrexate—germ cell cancer	0.000226	0.00101	CcSEcCtD
Mefloquine—Hypersensitivity—Methotrexate—germ cell cancer	0.000211	0.000944	CcSEcCtD
Mefloquine—Asthenia—Methotrexate—germ cell cancer	0.000205	0.000919	CcSEcCtD
Mefloquine—Pruritus—Methotrexate—germ cell cancer	0.000202	0.000906	CcSEcCtD
Mefloquine—Diarrhoea—Methotrexate—germ cell cancer	0.000195	0.000876	CcSEcCtD
Mefloquine—Dizziness—Methotrexate—germ cell cancer	0.000189	0.000847	CcSEcCtD
Mefloquine—ABCB1—brain—germ cell cancer	0.000184	0.000669	CbGeAlD
Mefloquine—Vomiting—Methotrexate—germ cell cancer	0.000182	0.000814	CcSEcCtD
Mefloquine—Rash—Methotrexate—germ cell cancer	0.00018	0.000808	CcSEcCtD
Mefloquine—Dermatitis—Methotrexate—germ cell cancer	0.00018	0.000807	CcSEcCtD
Mefloquine—Headache—Methotrexate—germ cell cancer	0.000179	0.000802	CcSEcCtD
Mefloquine—ABCB1—lymph node—germ cell cancer	0.000177	0.000646	CbGeAlD
Mefloquine—HBA2—Metabolism—SLC2A3—germ cell cancer	0.000173	0.0134	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—SLC22A3—germ cell cancer	0.00017	0.0132	CbGpPWpGaD
Mefloquine—Nausea—Methotrexate—germ cell cancer	0.00017	0.000761	CcSEcCtD
Mefloquine—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	0.00015	0.0116	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—CRABP1—germ cell cancer	0.000139	0.0108	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—SLC2A3—germ cell cancer	0.000131	0.0102	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—SLC22A3—germ cell cancer	0.000129	0.01	CbGpPWpGaD
Mefloquine—ADORA2A—G alpha (s) signalling events—AVP—germ cell cancer	0.000116	0.00898	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—CRABP1—germ cell cancer	0.000105	0.00818	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.000104	0.00809	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—AVP—germ cell cancer	0.000102	0.0079	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGF4—germ cell cancer	9.58e-05	0.00745	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	8.04e-05	0.00624	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—OXT—germ cell cancer	7.93e-05	0.00616	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KITLG—germ cell cancer	7.87e-05	0.00612	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—AVP—germ cell cancer	7.85e-05	0.0061	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—FGF4—germ cell cancer	7.37e-05	0.00573	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	7.13e-05	0.00554	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—INHA—germ cell cancer	6.37e-05	0.00495	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—OXT—germ cell cancer	6.12e-05	0.00475	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—KITLG—germ cell cancer	6.06e-05	0.00471	CbGpPWpGaD
Mefloquine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	5.89e-05	0.00458	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGFR3—germ cell cancer	5.85e-05	0.00455	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—INHA—germ cell cancer	5.68e-05	0.00441	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—KLF4—germ cell cancer	5.67e-05	0.00441	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	5.51e-05	0.00428	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—AVP—germ cell cancer	5.43e-05	0.00422	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—KIT—germ cell cancer	5.37e-05	0.00418	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—KLF4—germ cell cancer	5.06e-05	0.00393	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.75e-05	0.00369	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—FGFR3—germ cell cancer	4.5e-05	0.0035	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—OXT—germ cell cancer	4.48e-05	0.00348	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.36e-05	0.00339	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	4.24e-05	0.00329	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—AVP—germ cell cancer	4.19e-05	0.00326	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—KIT—germ cell cancer	4.13e-05	0.00321	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—OXT—germ cell cancer	4.07e-05	0.00316	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	3.74e-05	0.00291	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—OXT—germ cell cancer	3.46e-05	0.00269	CbGpPWpGaD
Mefloquine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	3.24e-05	0.00252	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—TP53—germ cell cancer	3.21e-05	0.00249	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—OXT—germ cell cancer	3.14e-05	0.00244	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—AVP—germ cell cancer	3.07e-05	0.00239	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—AVP—germ cell cancer	2.79e-05	0.00217	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—MYC—germ cell cancer	2.78e-05	0.00216	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—SLC2A3—germ cell cancer	2.63e-05	0.00205	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—SLC22A3—germ cell cancer	2.59e-05	0.00202	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.51e-05	0.00195	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—TP53—germ cell cancer	2.48e-05	0.00192	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.45e-05	0.0019	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—SLC2A3—germ cell cancer	2.42e-05	0.00188	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.41e-05	0.00187	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—OXT—germ cell cancer	2.4e-05	0.00187	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—SLC22A3—germ cell cancer	2.38e-05	0.00185	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—AVP—germ cell cancer	2.37e-05	0.00184	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—SLC2A3—germ cell cancer	2.35e-05	0.00183	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	2.32e-05	0.0018	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—SLC22A3—germ cell cancer	2.31e-05	0.0018	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—TP53—germ cell cancer	2.28e-05	0.00178	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—AVP—germ cell cancer	2.15e-05	0.00167	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CRABP1—germ cell cancer	2.11e-05	0.00164	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	2.06e-05	0.0016	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—FGF4—germ cell cancer	2.05e-05	0.00159	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—CRABP1—germ cell cancer	1.94e-05	0.00151	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—HRAS—germ cell cancer	1.9e-05	0.00148	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CRABP1—germ cell cancer	1.89e-05	0.00147	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—OXT—germ cell cancer	1.86e-05	0.00144	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—H2AFZ—germ cell cancer	1.83e-05	0.00142	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—HRAS—germ cell cancer	1.79e-05	0.00139	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—HRAS—germ cell cancer	1.69e-05	0.00132	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—KITLG—germ cell cancer	1.68e-05	0.00131	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—AVP—germ cell cancer	1.65e-05	0.00128	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FGF4—germ cell cancer	1.58e-05	0.00123	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—HRAS—germ cell cancer	1.46e-05	0.00113	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—H2AFZ—germ cell cancer	1.41e-05	0.0011	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—KITLG—germ cell cancer	1.3e-05	0.00101	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—HRAS—germ cell cancer	1.3e-05	0.00101	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—AVP—germ cell cancer	1.27e-05	0.000988	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—FGFR3—germ cell cancer	1.25e-05	0.000973	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—KIT—germ cell cancer	1.15e-05	0.000893	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SLC2A3—germ cell cancer	1.15e-05	0.000891	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—SLC22A3—germ cell cancer	1.13e-05	0.000877	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.13e-05	0.000877	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	1.09e-05	0.000848	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SLC2A3—germ cell cancer	1.08e-05	0.000839	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—SLC22A3—germ cell cancer	1.06e-05	0.000827	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FGFR3—germ cell cancer	9.67e-06	0.000751	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CRABP1—germ cell cancer	9.2e-06	0.000715	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	8.97e-06	0.000697	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—KIT—germ cell cancer	8.88e-06	0.00069	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CRABP1—germ cell cancer	8.67e-06	0.000674	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—HRAS—germ cell cancer	8.41e-06	0.000653	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC2A3—germ cell cancer	7.06e-06	0.000549	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—SLC22A3—germ cell cancer	6.96e-06	0.00054	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—HRAS—germ cell cancer	6.49e-06	0.000505	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MYC—germ cell cancer	6.33e-06	0.000492	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CRABP1—germ cell cancer	5.67e-06	0.000441	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TP53—germ cell cancer	5.2e-06	0.000404	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—HRAS—germ cell cancer	4.97e-06	0.000386	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MYC—germ cell cancer	4.88e-06	0.00038	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TP53—germ cell cancer	4.01e-06	0.000312	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—HRAS—germ cell cancer	3.84e-06	0.000298	CbGpPWpGaD
